Physician profile
Stephen J Schreck
NPI 1053313023
$1,819.70
in general payments reported to CMS, 2019-2025
23 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $167 · 2021: $105 · 2022: $262 · 2023: $309 · 2024: $425 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,182.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $280.04 | 2019-2024 | Core, Sonopet Iq |
| Genzyme Corporation | $224.56 | 2023-2025 | |
| Acclarent, INC | $204.52 | 2021-2023 | Relieva Spinplus |
| Inspire Medical Systems, INC. | $198.08 | 2024-2025 | Inspire |
| Optinose US, INC. | $171.86 | 2021-2024 | |
| Aerin Medical INC. | $161.58 | 2024-2025 | |
| Integra Lifesciences Corporation | $114.67 | 2023-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Glaxosmithkline, LLC. | $90.75 | 2022-2025 | Nucala |
| Kaleo, INC. | $57.41 | 2021-2023 | Auvi-Q |
| Amgen INC. | $45.35 | 2019-2025 | Uplizna |
| Phathom Pharmaceuticals, INC. | $41.91 | 2024 | Voquezna |
| Baxter Healthcare | $37.68 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $36.97 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $22.24 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.26 | 2025 | Walterlorenz Surgical Assist Arm |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $16.11 | 2024 | Coolseal Generator |
| Astrazeneca Pharmaceuticals LP | $15.84 | 2025 | Tezspire |
| Polynovo North America LLC | $15.02 | 2023 | |
| Alk-Abello, INC | $14.90 | 2024 | Alternaria Tenuis, Pre-Pen, Standardized Mite D. Farinae |
| Tactile Systems Technology INC | $14.70 | 2019 | |
| Medline Industries LP | $13.90 | 2019 | |
| Cook Medical LLC | $12.04 | 2021 | |
| Merck Sharp & Dohme LLC | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Schreck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.